TDF (tenofovir disproxil fumarate)/Viread Lawsuits
Gilead markets their TDF drugs under the brand names Atripla, Complera, Stribild, Truvada, and Viread. In their lawsuits, HIV patients assert that Gilead didn’t warn them of potentially life-threatening side effects. In addition, plaintiffs claim that Gilead purposely prevented a safer version of its medications from going to market in order to maximize profits from sales of TDF-based medications. Gilead’s motive for holding back a safer alternative therapy was pure greed.
The national law firm of Baron & Budd has battled appalling corporate behavior such as Gilead’s for more than forty years. If you were prescribed a tenofovir DF medication and suffered severe side effects as a result, we may be able to help.
GET STARTED ONLINE
How TDF Works
Human immunodeficiency virus is a persistent opportunistic infection which attacks the body’s immune system. Without medication to hold infection in check, HIV rapidly multiplies throughout the body, destroying immune cells and leaving patients susceptible to severe and potentially deadly infections.
The U.S. Food and Drug Administration (FDA) approved tenofovir DF for use in adults in 2001. TDF is designed to block the formation of an enzyme that allows the virus to multiply and can help reduce the severity of the HIV infection. This helps patients control their virus and enables them to lead long term healthier lives while also lowering the risk of infection to others.
The use of tenofovir DF has been linked to a buildup of lactic acid in the blood, called lactic acidosis, severe liver problems, kidney failure, and bone injuries. Japanese researchers published a study in 2017 which found that TDF use can lead to chronic kidney disease. According to scientists, prolonged use of the drug increases the risk of developing a potentially life-threatening condition. TDF use may also increase a patient’s risk for bone loss. A Stanford University study in 2016 found greater bone mineral density loss associated with TDF than with tenofovir alafenamide fumarate (TAF). A 2018 study published in the journal Clinical Science revealed that patients who were prescribed medications containing tenofovir DF suffered substantially more loss of hip bone density.
Talk to a Lawyer
Baron & Budd may be able to help if you took a drug containing tenofovir DF and suffered severe medical side effects as a result. The lawyers at Baron & Budd do not tolerate unscrupulous pharmaceutical companies that put profits before the safety of patients who take their medications. We work diligently to hold unethical drug manufacturers accountable for their actions. Please call or contact us online to learn more.